Drug repositioning is a strategy to identify new uses for existing, approved, or research
drugs that are outside the scope of its original medical indication. Drug repurposing is based …

The wealth of knowledge and omic data available in drug research allowed the rising of
several computational methods in drug discovery field yielding a novel and exciting …

Experimental drug development is time-consuming, expensive and limited to a relatively
small number of targets. However, recent studies show that repositioning of existing drugs …

Background Given the costly and time consuming process and high attrition rates in drug
discovery and development, drug repositioning or drug repurposing is considered as a …

Network-based computational biology, with the emphasis on biomolecular interactions and
omics-data integration, has had success in drug development and created new directions …

Background The process of drug discovery and development is time-consuming and costly,
and the probability of success is low. Therefore, there is rising interest in repositioning …

Drug repositioning can drastically decrease the cost and duration taken by traditional drug
research and development while avoiding the occurrence of unforeseen adverse events …

Finding new applications for existing pharmaceuticals, known as drug repositioning, is a
validated strategy for resolving the problem of high expenditure but low productivity in drug …

Motivation: The emergence of network medicine not only offers more opportunities for better
and more complete understanding of the molecular complexities of diseases, but also …

Drug repositioning, also known as drug repurposing or reprofiling, is the process of finding
new indications for established drugs. Because drug repositioning can reduce costs and …